The U.S. Food and Drug Administration has approved the first gene therapy for treating genetic hearing loss, marking a significant advancement in genetic medicine. This decision follows years of research and clinical trials demonstrating the effectiveness of the new treatment.
The ongoing war in Gaza has led to a significant increase in suffering among children, with many losing their hearing due to repeated explosions and a lack of necessary medical care. Reports indicate that approximately <strong>35,000 children</strong> in the region are at risk of hearing loss.
The Israeli blockade and restrictions on medical supplies have exacerbated the suffering of children in Gaza, with approximately 35,000 children experiencing hearing loss due to explosions and lack of healthcare.